About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Nr4a2tm1.1Pcn
targeted mutation 1.1, Pierre Chambon
MGI:4437024
Summary 6 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Nr4a2tm1.1Pcn/Nr4a2tm1.1Pcn Not Specified MGI:4437055
cn2
Nr4a2tm1.1Pcn/Nr4a2tm1.1Pcn
Slc6a3tm1(cre)Lrsn/Slc6a3tm1(cre)Lrsn
involves: 129S1/Sv * 129X1/SvJ MGI:4437054
cn3
Nr4a2tm1.1Pcn/Nr4a2+
Foxp3tm4(YFP/icre)Ayr/Foxp3+
involves: 129S1/Sv * 129X1/SvJ MGI:5547375
cn4
Foxp3tm4(YFP/icre)Ayr/Foxp3+
Nr4a2tm1.1Pcn/Nr4a2tm1.1Pcn
involves: 129S1/Sv * 129X1/SvJ MGI:5547376
cn5
Nr4a2tm1.1Pcn/Nr4a2tm1.1Pcn
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
involves: C57BL/6 * C57BL/6NTac MGI:5547377
cn6
Nr4a2tm1.1Pcn/Nr4a2tm1.1Pcn
Tg(Lck-cre)1Jtak/0
Not Specified MGI:5547378


Genotype
MGI:4437055
cn1
Allelic
Composition
Nr4a2tm1.1Pcn/Nr4a2tm1.1Pcn
Genetic
Background
Not Specified
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Nr4a2tm1.1Pcn mutation (0 available); any Nr4a2 mutation (44 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
N
• injection of adenovirus expressing cre do not alter brain morphology, expression of midbrain dopamine neuron markers, or microglia activation
• mice injected with an adenovirus expressing cre exhibit a progressive decrease in dopaminergic neurons compared with wild-type mice

behavior/neurological
• 3 to 4 months after injection with an adenovirus expressing cre, mice exhibit impaired performance in a stepping test compared with wild-type mice

homeostasis/metabolism
• in the dorsolateral striatum and areas innervated by scattered ventral tegmental area of mice injected with an adenovirus expressing cre




Genotype
MGI:4437054
cn2
Allelic
Composition
Nr4a2tm1.1Pcn/Nr4a2tm1.1Pcn
Slc6a3tm1(cre)Lrsn/Slc6a3tm1(cre)Lrsn
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Nr4a2tm1.1Pcn mutation (0 available); any Nr4a2 mutation (44 available)
Slc6a3tm1(cre)Lrsn mutation (1 available); any Slc6a3 mutation (66 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• mice do not survive beyond 3 weeks
• however, leaving pups with mothers improves perinatal survival beyond 3 weeks

nervous system
• expression of midbrain dopamine neuron markers is lost compared to in wild-type mice
• mice exhibit a rapid loss of substantia nigra pars compacta cell bodies with only scattered ventral tegmental area neurons remaining compared with wild-type mice

behavior/neurological
• at 4 and 14 months
• L-DOPA-treated mice exhibit hyperactivity unlike similarly treated wild-type mice
• L-DOPA-treated mice exhibit repetitive behaviors (including repetitive gnawing, excessive grooming, and self-injury) unlike similarly treated wild-type mice

homeostasis/metabolism
• at P1, striatal dopamine levels are decreased to 14% of wild-type
• at P14, the ratio of homovanillic acid (HVA) to dopamine is increased indicating increased dopamine turnover compared to in wild-type mice
• at P60, striatal dopamine levels are almost completely lost unlike in wild-type mice
• at P60, dopamine levels are more severely decreased in the caudate putamen compared to in the nucleus accumbens
• serotonin levels in the caudate putamen and nucleus accumbens are increased compared to in wild-type mice
• L-DOPA-treated mice exhibit hyperactivity and repetitive behaviors unlike similarly treated wild-type mice

growth/size/body
• at 2 months, mice left with their mothers after weaning are 40% smaller than wild-type mice




Genotype
MGI:5547375
cn3
Allelic
Composition
Nr4a2tm1.1Pcn/Nr4a2+
Foxp3tm4(YFP/icre)Ayr/Foxp3+
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Foxp3tm4(YFP/icre)Ayr mutation (2 available); any Foxp3 mutation (58 available)
Nr4a2tm1.1Pcn mutation (0 available); any Nr4a2 mutation (44 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• Treg cells are not properly maintained

hematopoietic system
• Treg cells are not properly maintained




Genotype
MGI:5547376
cn4
Allelic
Composition
Foxp3tm4(YFP/icre)Ayr/Foxp3+
Nr4a2tm1.1Pcn/Nr4a2tm1.1Pcn
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Foxp3tm4(YFP/icre)Ayr mutation (2 available); any Foxp3 mutation (58 available)
Nr4a2tm1.1Pcn mutation (0 available); any Nr4a2 mutation (44 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• regulatory T cells are not properly maintained
• slightly attenuated suppressive activity
• in a transfer model of colitis, regulatory T cells fail to inhibit wasting disease and colitis compared with wild-type cells

hematopoietic system
• regulatory T cells are not properly maintained
• slightly attenuated suppressive activity
• in a transfer model of colitis, regulatory T cells fail to inhibit wasting disease and colitis compared with wild-type cells




Genotype
MGI:5547377
cn5
Allelic
Composition
Nr4a2tm1.1Pcn/Nr4a2tm1.1Pcn
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
Genetic
Background
involves: C57BL/6 * C57BL/6NTac
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm9(cre/ESR1)Arte mutation (2 available); any Gt(ROSA)26Sor mutation (993 available)
Nr4a2tm1.1Pcn mutation (0 available); any Nr4a2 mutation (44 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• increased under Th1-, Th17- and induced regulatory T cell-skewing conditions following tamoxifen-treatment
• reduced under Th17-skewing conditions following tamoxifen-treatment
• reduced regulatory T cell differentiation under induced regulatory T cell-skewing conditions following tamoxifen-treatment

hematopoietic system
• increased under Th1-, Th17- and induced regulatory T cell-skewing conditions following tamoxifen-treatment
• reduced under Th17-skewing conditions following tamoxifen-treatment
• reduced regulatory T cell differentiation under induced regulatory T cell-skewing conditions following tamoxifen-treatment




Genotype
MGI:5547378
cn6
Allelic
Composition
Nr4a2tm1.1Pcn/Nr4a2tm1.1Pcn
Tg(Lck-cre)1Jtak/0
Genetic
Background
Not Specified
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Nr4a2tm1.1Pcn mutation (0 available); any Nr4a2 mutation (44 available)
Tg(Lck-cre)1Jtak mutation (3 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging

immune system
N
• surviving mice exhibit no auto-immune disease symptoms up to 4 months of age
• mice exhibit normal numbers of regulatory T cells in the thymus and spleen
• DSS-treated mice exhibit accelerated body weight loss, severe intestinal inflammation, increased Th1 cells and attenuated increase of regulatory T cells in the colon and cecum lamina propria compared with control mice
• increased under Th1-, Th17- and induced regulatory T cell-skewing conditions
• reduced under Th17-skewing conditions
• CD44highCD62Llow-activated and IFN-gamma CD4+ T cells
• in DSS-treated mice
• reduced regulatory T cell differentiation under induced regulatory T cell-skewing conditions
• in DSS-treated mice

digestive/alimentary system
• DSS-treated mice exhibit accelerated body weight loss, severe intestinal inflammation, increased Th1 cells and attenuated increase of regulatory T cells in the colon and cecum lamina propria compared with control mice

growth/size/body
• accelerated in DSS-treated mice

hematopoietic system
• increased under Th1-, Th17- and induced regulatory T cell-skewing conditions
• reduced under Th17-skewing conditions
• CD44highCD62Llow-activated and IFN-gamma CD4+ T cells
• in DSS-treated mice
• reduced regulatory T cell differentiation under induced regulatory T cell-skewing conditions
• in DSS-treated mice





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory